NHS Greater Glasgow and Clyde Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01704339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NHS Greater Galsgow and Clyde

Active Ingredients

Drugs in Phase 4 Trials (1)

capsaicin (qutenza) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ischemia (Phase 4)

Kidney Failure, Chronic (Phase 4)

Neuralgia (Phase 4)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1